How can the latest long-term TAVI evidence impact our daily decision-making?
Sponsored by Medtronic
Summary
Join Antoinette Neylon, Didier Tchétché and Ole De Backer as they discuss the key issues in terms of lifetime management of TAVI patients, the learnings from the 10-year TAVI NOTION, the 4-year Evolut Low Risk, and the impact on initial device choice.
This interview was filmed at PCR London Valves 2023: see more videos here.